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Introduction: The western population is ageing. It is unknown whether age at diagnosis affects the severity of
Rheumatoid Arthritis (RA), we therefore performed the present study.
Method: 1,875 RA-patients (7,219 radiographs) included in five European and North-American cohorts (Leiden-EAC,
Wichita, Umeå, Groningen and Lund) were studied on associations between age at diagnosis and joint damage
severity. In 698 Leiden RA-patients with 7-years follow-up it was explored if symptom duration, anti-citrullinated-
peptide-antibodies (ACPA), swollen joint count (SJC) and C-reactive-protein (CRP) mediated the association of age
with joint damage. Fifty-six other RA-patients of the EAC-cohort underwent baseline MRIs of wrist, MCP and
MTP-joints; MRI-inflammation (RAMRIS-synovitis plus bone marrow edema) was also evaluated in mediation
analyses. Linear regression and multivariate normal regression models were used.
Results: Analysis on the five cohorts and the Leiden-EAC separately revealed 1.026-fold and 1.034-fold increase
of radiographic joint damage per year increase in age (β=1.026, 1.034, both p<0.001); this effect was present at
baseline and persisted over time. Age correlated stronger with baseline erosion-scores compared to joint space
narrowing (JSN)-scores (r=0.38 versus 0.29). Symptom duration, ACPA, SJC and CRP did not mediate the association of
age with joint damage severity. Age was significantly associated with the MRI-inflammation-score after adjusting for
CRP and SJC (β=1.018, p=0.027). The association of age with joint damage (β=1.032, p=0.004) decreased after also
including the MRI-inflammation-score (β=1.025, p=0.021), suggesting partial mediation.
Conclusion: RA-patients presenting at higher age have more severe joint damage; this might be partially explained by
more severe MRI-detected inflammation at higher age.Introduction
The western population is ageing. Consequently, the
number of patients with rheumatoid arthritis (RA) pre-
senting at an older age is increasing [1, 2]. Ageing is as-
sociated with alterations and remodelling of the innate
and adaptive immune system (immunosenescence) [3–5].
It is unclear to what extent ageing or age-associated
changes in function of immune cells influence the severity
of RA. If RA severity differs for patients diagnosed at dif-
ferent age categories, this is relevant for clinical practice.
Some previous studies suggest that older patients with
RA have more joint damage [6–11], whereas other* Correspondence: L.Mangnus@lumc.nl
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joint damage in older patients with RA [14]. Most studies
performed analyses at a single time point [7–10, 13, 14]
and all studied patients categorized as younger or older
[6–14]. The first aim of the present study was to explore
the association between age and severity of joint damage
in more detail. Patients with RA included in one North-
American and four European longitudinal cohorts were
studied for severity of joint damage at disease presentation
and during the course of the disease. We analysed age as a
continuous variable to obtain optimal insight into the ef-
fects of age.
Second, no studies have explored processes underlying
the association between age at disease onset and radio-
graphic joint damage. First, because joint damage mea-
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JSN may occur not only due to RA but also reflect de-
generation. An increase in total SHS severity at older
age could therefore be due to a disproportional increase
in JSN. Additionally, based on general knowledge of risk
factors for progressive joint damage in RA (longer symp-
tom duration, presence of RA-related auto-antibodies,
higher numbers of swollen joints and elevated acute-phase
reactants are all associated with more severe damage), we
made several other hypotheses. We assumed that older pa-
tients present at a later point in time, and therefore have
more severe joint damage. In addition, as the prevalence of
RA-related auto-antibodies in the general population in-
creases with increasing age, we hypothesized that patients
with RA presenting at older age are more often rheumatoid
factor (RF)-positive or anti-citrullinated peptide antibodies
(ACPA)-positive and therefore have more severe disease
[8, 11–13, 15–20]. Likewise we postulated that inflamma-
tion at diagnosis is more severe at older age resulting in
more joint damage. Inflammation was evaluated using
traditional measures (swollen joint count (SJC), C-reactive
protein (CRP)) and using magnetic resonance imaging
(MRI), which is more sensitive in detecting local inflamma-
tion [21, 22]. We also aimed to explore these hypotheses.
Thus the first aim of this study was to explore the
association of age with joint damage severity in more
detail and, second, we aimed to increase the understand-
ing of the processes underlying the association between
age of disease onset and the severity of the disease course.
Methods
Study population
To determine the association between age at diagnosis
and severity of joint damage, patients with RA included
in five longitudinal inception cohorts were studied. In
total this comprised 1,875 patients with 7,219 sets of ra-
diographs made at baseline and during follow up. Patients
were included in cohorts of the Leiden early arthritis clinic
(EAC), Groningen (both the Netherlands), Wichita (USA),
Umeå and Lund (both Sweden). All patients with RA
fulfilled the 1987 criteria for RA except for the Lund
cohort where the 1958 criteria were used. The age at
diagnosis was recorded in all cohorts. For all studies
the regional ethics committee approved the study and
all participants gave their written informed consent. Ex-
tensive descriptions of these cohorts are presented else-
where [23–26], short descriptions are provided below.
Leiden early arthritis clinic (EAC) cohort
Patients with early RA (n = 698) between 1993 and 2006
were included [23]. From these patients 3,643 sets of
radiographs of the hands and feet were obtained during
7 years of follow up. Follow-up visits, including radiographs,
were done yearly. All radiographs were chronologicallyscored by an experienced reader, blinded to the clinical data,
according to the SHS-method. The intra-reader intra-class
correlation coefficient (ICC) was 0.91. The applied treatment
strategies changed over time, as described elsewhere [27];
the inclusion periods were used to adjust for differences in
applied treatments. The data for these patients were used
for the mediation analyses as they contained most radio-
graphs and extensive data on clinical and serologic variables.
A second study population of patients with RA was
included in the EAC in 2010–2012. In addition to the
general EAC-protocol including radiographs, these con-
secutively included patients had contrast-enhanced 1.5 T
MRI of unilateral metacarpophalangeal (MCP), wrist and
metatarsophalangeal (MTP) joints at baseline. Patients
who had 1-year follow up, including radiographs, were se-
lected (n = 56). The MRI (ONI-MSK-Extreme 1.5 T MRI
(GE, WI, USA)) was performed at inclusion, on the
most symptomatic side or the dominant side in the case
of equally severe symptoms. Scanning was done according
to the RA MRI score (RAMRIS), with contrast enhance-
ment. The scan protocol is described in Additional file 1.
MRI-scoring was done by two trained readers blinded to
any clinical data [28–30]. The within-reader ICCs were
0.98 and 0.83, and the inter-reader ICC 0.82. The mean
score of both readers was studied.Wichita
This North-American cohort consisted of 293 patients
that were diagnosed between 1963 and 1999 [24]. In this
cohort 1,062 radiographs were made during 15 years of
follow up. All radiographs were chronologically scored
by an experienced reader using the SHS (ICC 0.98) [31].Umeå
The third cohort consisted of 459 patients included be-
tween 1995 and 2010 [6]. These patients had radiographs
at baseline and 2 years: 868 radiographs were obtained
and were scored by two trained rheumatologists according
to the Larsen score [32, 33]. Treatment strategies differed
between 1995 and 1999, 2000 and 2005, and 2006 and
2010, with less severe radiographic progression in the
subsequent treatment periods.Groningen
This dataset included 278 patients with RA who were
diagnosed between 1945 and 2001. During 14 years of
follow up 865 radiographs were obtained that were chrono-
logically scored according to the SHS by one of two readers
(intra-reader ICC >0.90 inter-reader ICC 0.96) [34]. Joint
destruction was less severe after 1990, which coincides with
the introduction of treatment with disease-modifying anti-
rheumatic drugs (DMARDs).
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This cohort consist of 147 patients recruited from primary
care units in the area of Lund from 1985–1989 [26]: 781
radiographs were obtained during 5 years of follow up.
These radiographs were scored according to the Larsen
score (ICC 0.94) [32, 35]. All results for age in all datasets
in this study represent the age of the patient at the time
of diagnosis. At the baseline visit, the date of birth or
age itself was recorded.
Analyses
First, the associations between age at diagnosis and the
severity of joint damage were evaluated for each cohort
separately. A multivariate normal regression model for
longitudinal data [27] was used with radiographic scores
as the outcome and age as the continuous independent
variable. The radiographic scores were log10-transformed
(log10 (score+1)) to approximate a normal distribution. In
all cohorts the residuals of the models were normally dis-
tributed around zero, indicating a good fit of the models
(Additional file 2: Figure S1). This repeated measurement
analysis takes the correlation between repeated mea-
surements within patients into account. A heterogeneous
first-order autoregressive (ARH1) correlation structure
was used, assuming a stronger correlation for measure-
ments taken in a shorter period of time than for those
over a longer period. As described elsewhere in detail [27]
this model is able to test for two effects: first the model
can be used to analyse whether patients with a risk factor
have more severe joint damage at any point in time; this
reflects a constant effect size over time.
Second, the model can be used to analyse whether pa-
tients have more severe radiographic progression over
time; this present the steepness of the curve of joint dam-
age over time (risk factor*time). In the evaluated cohorts,
the radiographic data were plotted (before starting with
statistical analysis); this suggested an effect that is constant
over time and not a progression effect. Therefore analyses
were focussed on the constant effect and all results pre-
sented (effect sizes, p values) were those of a constant ef-
fect, thus, this concerns a difference in joint destruction
that was equally present at every time point.
In all datasets, analyses were adjusted for gender. In
the cohorts that included patients in periods with differ-
ent treatments strategies (EAC, Umeå and Groningen)
an additional adjustment was made for the inclusion
period (as proxy for treatment strategy) as radiographic
joint damage varied between different inclusion periods.
As the analyses were performed on the log-scale, the
resulting effect estimates were back-transformed to the
normal scale and indicated the fold increase in joint
damage per year of increase in age at diagnosis. Thus,
this outcome indicates a relative increase in joint dam-
age and is unit-free. This allowed us to enter the effectsof the five different cohorts in an inverse-weighted
meta-analysis. This method weights the results with a
low standard error stronger than results with a higher
standard error, preventing over-representation of the less
precise data on the overall outcome. A random-effect
model was used.
To explore whether the increase in total SHS at increas-
ing age was explained by a disproportionate increase in
JSN, possibly reflecting age-related degenerative changes,
the total SHS at baseline of the 698 Leiden RA patients
was split into erosion score and JSN score. Pearson’s
correlation coefficients were determined and equality/
inequality of the two correlation coefficients was assessed
using the corcor command. Similarly, the total SHS was
split for separate locations; predilection locations for
primary osteoarthritis (proximal interphalangeal (PIP)-
joints, carpometacarpal-1 (CMC-1)-joints and MTP-1 plus
interphalangeal-1 joints were compared to other joints.
Mediation analyses were used to identify potential mech-
anisms underlying the association between age at disease
onset and radiographic joint damage. Mediation analyses
were performed according to Baron and Kenny (Fig. 1)
[36]. First (step 1), the mediator variables were regressed
on the independent variable (age); the independent variable
should significantly affect the mediator variables. Second
(step 2), regression analysis of the dependent variable
(radiographic joint damage) on the independent variable
(age) was done. In this analysis the independent variable
must significantly affect the dependent variable. Third
(step 3), the dependent variable was regressed on the
independent and mediator variable. When mediation
occurs, the mediator variable significantly affects the
dependent variable and the effect of the independent
variable on the dependent variable decreases (partial
mediation) or disappears completely (full mediation).
Symptom duration at baseline, ACPA (anti-CCP2), IgM-RF,
CRP, SJC and TJC were assessed as mediators. Linear
or logistic regression was used as appropriate for step 1.
For steps 2 and 3 the multivariate normal regression
model was used as described.
Analyses were performed with SPSS V20.0.0; the meta-
analysis and the equality of the correlation test were per-
formed using STATA/SE V12.1.
Results
Age at diagnosis and severity of radiographic joint
damage
First, the association between age and severity of joint
damage observed on radiographs was explored separately
in each cohort. Baseline characteristics of these patients
are presented in Table 1. In all cohorts an increase in age
at diagnosis was associated with more severe joint damage
at baseline and this effect persisted over time. Combining
all five cohorts in a meta-analysis revealed that patients
Fig. 1 Schematic overview of the causal paths that were studied using mediation models as described by Baron and Kenny. The figure illustrates
two causal paths that lead to an outcome. A direct path from independent to dependent variable (b) and an indirect path from an independent
to a dependent variable through a mediator variable (a,c). To test mediation three tests have to be performed according to Baron and Kenny
[36]. 1) The mediator variables were regressed on the independent variable (a), the independent variable should significantly affect the mediator
variables. 2) regression analysis of the dependent variable on the independent variable was done (b); in this analysis the independent variable
must significantly affect the dependent variable. 3) The dependent variable was regressed on the independent and mediator variable (b and c).
When mediation occurs the mediator variable significantly affects the dependent variable and the effect of the independent variable on the
dependent variable is closer to zero. In this study we tested whether different mediators could influence the effect of age on radiographic joint
damage. The tested mediators were symptom duration at diagnosis, swollen joint count (SJC), tender joint count (TJC), C-reactive protein (CRP),
anti-citrullinated protein antibody (ACPA), rheumatoid factor (RF), and inflammation detected on magnetic resonance imaging (MRI). SHS Sharp-van der
Heijde score
Table 1 Characteristics of patients with rheumatoid arthritis included in the longitudinal cohorts studied. Age, symptom duration,
TJC, SJC, CRP, ACPA and RF were assessed at baseline
EAC Part 1 EAC Part 2 (MRI) Wichita Umeå Groningen Lund
Total number of patients 698 56 293 459 278 147
Total number of radiographs 3.643 105 1.062 868 865 781
Mean number of radiographs per patient (SD) 5.2 (2.1) 1.9 (0.3) 3.6 (2.0) 1.9 (0.3) 3.1 (1.4) 5.3 (0.8)
Year of diagnosis 1993–2006 2010–2012 1963–1999 1995–2010 1945–2001 1985–1989
Radiographic follow up in years 7 1 15 2 14 5
Method of scoring SHS SHS SHS Larsen SHS Larsen
Age, years
Mean (SD) 56.6 (15.6) 55.9 (14.2) 48.8 (14.2) 53.9 (14.5) 49.3 (12.6) 50.7 (11.5)
Median (IQR) 58 (46–68) 59 (46–65) 49 (39–60) 56 (45–64) 50 (40–59) 51 (43–59)
Range 17.1–92.4 21.5–77.8 16.0–83.0 17.0–83.0 18.3–76.3 18.0–78.0
Female sex (%) 474 (67.8) 31 (55.4) 226 (77.1) 321 (69.2) 196 (70.5) 98 (66.7)
Symptom duration in weeks (IQR) 19 (11–37) 18 (11–32) NA NA NA 43 (29–62)
TJC (IQR) 8 (5.0–12.0) 7 (4.0–10.5) NA NA NA NA
SJC (IQR) 8 (4.0–14.0) 5 (3.5–10.0) NA NA NA NA
ESR (IQR) 33 (19–54) 25 (10–41) NA NA NA NA
CRP (IQR) 17 (8.0–40.0) 11 (3.0–20.5) NA NA NA NA
ACPA positivity (%) 365 (53.7) 33 (63.5) 238 (82.1) 339 (73.1) 162 (79.4) 114 (80.3)
RF positivity (%) 405 (58.2) 36 (64.3) NA NA 259 (93.8) 115 (80.3)
Age, symptom duration, TJC, SJC, ESR, CRP, ACPA and RF were assessed at baseline
EAC Early Arthritis Clinic, MRI magnetic resonance imaging, TJC tender joint count, SJC swollen joint count, CRP C-reactive protein, ESR erythrocyte sedimentation
rate, ACPA anti-citrullinated peptide antibodies, RF rheumatoid factor, SHS Sharp-van der Heijde
Mangnus et al. Arthritis Research & Therapy  (2015) 17:222 Page 4 of 10
Mangnus et al. Arthritis Research & Therapy  (2015) 17:222 Page 5 of 10had 1.026-fold more joint damage observed on radio-
graphs per year increase in age at any point during the dis-
ease course (β = 1.026, p <0.001, Fig. 2a). For illustration,
the predicted severity of joint damage per group of pa-
tients according to different age categories is depicted in
Fig. 2b, based on 698 patients with RA included in the
Leiden-EAC. Data for the other cohorts are depicted in
Additional file 3: Figure S2. Here joint damage increased
1.034-fold per year increase in age; this effect was constant
over time (β = 1.034, p <0.001).
Correlation of age with erosion score and JSN score
The SHS at disease onset in patients with RA included
in the Leiden EAC were split into total erosion scores
and total JSN scores to explore whether age-related
degenerative changes explain the association between
age and total SHS score, and we assessed whether theFig. 2 Association between age at diagnosis and severity of joint
damage in five longitudinal cohorts summarized in a meta-analysis
(a) and depicted for patients with rheumatoid arthritis included in
the Leiden Early Arthritis Clinic (EAC) for different age categories (b).
a Age was entered as a continuous variable in the multivariate normal
regression analysis, because the plots of the raw data suggested no
interaction of age with time. The meta-analysis (inverse weighted
meta-analysis with a random-effect model) summarizes the effects of
the age of the different cohorts. An effect size of 1.034 represents a
1.034-fold increase in joint damage per year increase in age.
Because these effect sizes were unit-free they could be compared
in meta-analysis. b Although age was analyzed as a continuous variable,
the predicted Sharp-van der Heijde (SHS) scores per age-category were
plotted to illustrate the data. The SHS scores predicted by the
multivariate normal regression analysis are presentedcorrelation between age and JSN score was stronger
than the correlation between age and the erosion score.
Age at diagnosis was significantly correlated with both the
erosion and JSN scores (r = 0.38, p <0.001 and r = 0.29,
p <0.001 respectively, Fig. 3) at baseline. The correlation
coefficient of the erosion score was significantly higher
than that of the JSN score (p = 0.006). The association
between age and erosion and JSN score over time was
also assessed, and older age was associated with higher
erosion scores and higher JSN scores at all points in
time (β = 1.030, p <0.001, and β = 1.020, p <0.001, re-
spectively) (Fig. 4).
The total SHS score is also the sum of the scores of dif-
ferent joints. We hypothesized that some joints (predilec-
tion locations for primary osteoarthritis in particular, such
as CMC-1) are more frequently affected by age-related de-
generation. Therefore the total SHS score at baseline was
split for several regions and correlations between the SHS
score per region and age were determined. This revealed
that the correlation of CMC-1 was comparable to that
of the wrist (r = 0.26 and r = 0.23, both p <0.001). TheFig. 3 Correlation between age and Sharp-van der Heijde erosion
(a) and joint space narrowing scores (JSN) (b) at baseline
Fig. 4 Sharp-van der Heijde erosion score (a) and joint space narrowing
score (b) over time for patients with rheumatoid arthritis from the Early
Arthritis Clinic, categorized by age at diagnosis
Table 2 Mediation analysis in 698 patients with rheumatoid
arthritis from the Leiden Early Arthritis Clinic, with radiographic
severity of joint damage over 7 years as the outcome variable
Step 1: effect of age on possible mediators
Effect (β)a 95 % CI p value
SJC 1.00 1.00–1.01 0.11
TJC 1.00 1.00–1.01 0.55
Symptom duration 0.992 0.988–0.996 <0.001
CRP 1.016 1.011–1021 <0.001
RF 0.99 0.98–1.00 0.09
ACPA 0.98 0.97–0.99 <0.001
Step 2: effect of age on radiographic joint damage
Effect (β) 95 % CI p value
Ageing 1.034 1.029–1.040 <0.001
Step 3: effect of age and possible mediator on radiographic
joint damage
Effect (β) 95 % CI p value
SJC 1.00 0.99–1.00 0.23
Ageing 1.035 1.029–1.040 <0.001
TJC 1.00 0.98–1.01 0.76
Ageing 1.037 1.030–1.044 <0.001
Symptom duration 1.003 1.002–1.005 <0.001
Ageing 1.035 1.029–1.040 <0.001
CRP 1.003 1.001–1.005 0.003
Ageing 1.033 1.027–1.038 <0.001
ACPA 1.37 1.16–1.60 <0.001
Ageing 1.035 1.030–1.040 <0.001
RF 1.30 1.10–1.52 0.002
Ageing 1.034 1.029–1.039 <0.001
aThe effect size (β) of swollen joint count (SJC), tender joint count (TJC),
symptom duration and C-reactive protein (CRP) reflect the increase per year
increase of age. For example, the β for CRP is 1.016 this means that for every
year increase in age there is 1.016-fold increase in CRP. A β of 0.992 indicates
an increase 0.992- fold, hence actually a decrease. The effect size of anti-
citrullinated protein antibody (ACPA) and rheumatoid factor (RF) reflect the
odds ratio. Step 1, 2 and 3 of the mediation analyses are explained in Fig. 1. In
step 1 a linear or logistic regression was used, in step 2 and 3 a multivariate
normal regression analysis was used [27]. Also here the effects are per unit.
For example, the β for age on joint damage is 1.034/year this means that for
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(r = 0.20, 0.31 and 0.39 for MTP + IP-1, MCP joints
and PIP joints, all p <0.001), only in the MTP2−5 joints
the correlation of the SHS score with age was lower (r =
0.08, p = 0.03, Additional file 4: Figure S3). Together these
results suggest that degenerative changes at older age may
contribute to more severe joint damage in patients pre-
senting at older age but are clearly insufficient to explain
the total effect.every year increase in age there is an increase of 3.4 % this is equal to an
increase of 95.2 % every 20 years (1.034^20). All features (SJC, TJC, ACPA, RF,
symptom duration, and age) were assessed at baselineAge and symptom duration at first presentation
Because it is known that prolonged symptom duration at
first presentation is associated with more severe radio-
graphic progression [37, 38], we hypothesized that older
persons present with a longer symptom duration, hence
mediating the association with joint damage. Although lon-
ger symptom duration was associated with more joint dam-
age (β = 1.003, p <0.001), symptom duration was inversely
associated with age, (β = 0.99, p <0.001), hence older age
was associated with shorter symptom duration. Therefore,
symptom duration did not mediate the effect of age on
joint damage (Table 2).Age and RA-related auto-antibodies
The presence of ACPA and RF were strong risk factors
for radiographic progression (β = 1.37, p <0.001 and β =
1.30, p <0.001, respectively). These auto-antibodies can
mediate the association between age and joint destruc-
tion if age is associated with a higher prevalence of these
auto-antibodies. We observed no significant association
between age at onset and presence of RF (odds ratio
(OR) = 0.99, p= 0.09). The prevalence of ACPA was
lower when RA was diagnosed at an older age (OR =
0.98, p <0.001). Therefore, these auto-antibodies did not
Table 3 Mediation analysis in 56 patients with rheumatoid
arthritis from the Leiden Early Arthritis Clinic, with radiographic
severity of joint damage as the outcome
Step 1: effect of age on possible mediators
Effect (β) 95 % CI p value
MRI inflammation 1.018 1.002–1.034 0.027
Synovitis 1.011 1.00–1.024 0.092
BME 1.021 1.00–1.043 0.052
Step 2: effect of age on radiographic joint damage
Effect (β) 95 % CI p value
Ageing 1.032 1.010–1.055 0.004
Step 3: effect of age and possible mediator on radiographic
joint damage
Effect (β) 95 % CI p value
MRI inflammation 1.026 1.004–1.047 0.018
Ageing 1.025 1.004–1.047 0.021
Synovitis 1.069 0.97–1.17 0.15
Ageing 1.029 1.007–1.051 0.011
BME 1.039 1.011–1.067 0.007
Ageing 1.026 1.005–1.047 0.014
Step 1, 2 and 3 are explained in Fig. 1. In step 1 a linear regression is used, in
step 2 and 3 a multivariate normal regression analysis is used [27]. The effects
are per unit increase, for example per point increase in rheumatoid arthritis
magnetic resonance imaging score (RAMRIS) and per year increase in age; for
further explanation see legend of Table 2. MRI magnetic resonance imaging,
BME bone marrow edema
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(Table 2).
Age and clinical measures of joint inflammation
Next we explored whether the extent of joint inflamma-
tion, measured using the SJC and TJC at baseline, was a
mediator. Age at diagnosis was not associated with the
number of joints involved (β = 1.00, p = 0.11 and β = 1.00,
p = 0.55 for SJC and TJC, respectively). The SJC and TJC
were also not associated with radiographic joint damage
(β = 1.00, p = 0.23 and β = 1.00, p = 0.76); therefore these
clinical measures of local inflammation were not media-
tors (Table 2).
Age and serological measures of inflammation
Subsequently it was explored whether CRP, a measure of
systemic inflammation, was a mediator. CRP-levels in-
creased significantly with age (β = 1.016, p <0.001), indi-
cating that with every year increase in age the CRP
increased by 1.6 %. CRP-levels were also associated with
severity of joint damage (β = 1.003, p = 0.003). In the
third step of the mediation analysis, the association be-
tween age and joint damage was studied after adjustment
for CRP. This revealed a very slight decrease in effect size,
from 1.034 to 1.033 (Table 2), based on which it was con-
cluded that also CRP was not a mediator. Similar results
were seen when erythrocyte sedimentation rate (ESR) was
studied (data not shown).
Age and local inflammation measured by MRI
It is known that MRI of the extremities measures local
inflammation more sensitively than physical examination
and CRP [21, 22, 39]. To explore local inflammation in
more detail, additional mediation analysis was performed
in another group of patients with RA who underwent
MRI of the extremities at baseline (Table 3). The MRI
synovitis and bone marrow edema (BME) scores were
summed, yielding the MRI inflammation scores. Also in
this group of patients, an increase in age was associated
with more joint damage at baseline; also here the effect
was constant over time. (β = 1.032 p = 0.004). All subse-
quent analyses were adjusted for SJC and CRP to ensure
that the results for MRI-detected inflammation were not
explained by these traditional measures of inflammation.
It was observed that patients presenting at older age had
higher MRI inflammation scores (β = 1.018, p = 0.027)
and that higher MRI inflammation scores were associated
with radiographic joint damage at any point in time evalu-
ated (β = 1.026, p = 0.018). Then in step 3 of the medi-
ation analysis there was a decreased effect size of age with
structural damage when additionally adjusting for the
MRI inflammation score (β = 1.032 p = 0.004 to β = 1.025
p = 0.02), suggesting that MRI-detected inflammation is apartial mediator for the effect of age on radiographic joint
damage.
Discussion
The western population is ageing. Consequently the num-
ber of patients with RA diagnosed at an older age is rising
[1, 2]. It is generally hoped that the additional years of
life are spent in good health. RA, however, is associated
with decreased functioning and quality of life. Previous
studies on age and RA severity have contrasting results
[6, 7, 9, 40, 41]. The present study of patients with RA,
which included five longitudinal cohorts, showed that
older patients had more severe joint damage at diagno-
sis and this effect remained present during the disease
course. We evaluated several hypotheses to increase the
understanding of the processes driving the observations
of the influence of age. We observed that the effect was
partially and modestly mediated by MRI-detected inflam-
mation with increasing age.
Longitudinal data from five cohorts were studied on
the effect of age on the severity of joint damage. Because
of the presence of serial radiographic measurements multi-
variate normal regression analysis was used (this model is
similar to a linear mixed model, only no random effect is
added). For reasons of consistency this model was also
used in the mediation analysis in the second part of the
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already present at baseline and the mediation analyses
could also be done with joint damage at baseline as the
outcome. Repeating the mediation analysis with baseline
SHS as the outcome indeed revealed similar results (data
not shown).
Interestingly, some variables assessed in the mediation
analyses were inversely correlated with age. The symptom
duration at the time of diagnosis was shorter at older age,
indicating that older patients had less delay in getting
access to rheumatologic care. Thus, although we hy-
pothesized that older patients presented with more se-
vere damage due to having longer duration of disease,
older patients had a shorter period of symptoms at first
presentation, hence arguing against this hypothesis.
Also the prevalence of ACPA decreased at older age in
1,987-criteria-positive patients with RA, which is in con-
trast to the prevalence of ACPA in the general population
[15], but a lower frequency of ACPA amongst older pa-
tients with RA has been described before [6]. Several stud-
ies have observed higher CRP-levels in older patients with
RA [11, 16, 17], and we also observed this. However, the
effect size of the association between age and severity of
joint damage decreased very little after adjusting for CRP,
therefore CRP was not considered an evident mediator.
MRI of the extremities is sensitive in detecting local
inflammation and subclinical inflammation observed on
MRI has been found to be relevant for radiographic
progression of RA [21, 22]. The present data showed
that patients with RA presenting at an older age have
more MRI-detected inflammation. Ageing is associated
with an increase in pro-inflammatory status and a decline
in both T cell and B cell function [3–5]. Potentially,
changes in the immune system are underlying the current
observation of more severe inflammation on MRI at an
older age. Earlier studies have shown that the severity of
MRI-detected inflammation is associated with the severity
of radiographic joint damage and that this effect is inde-
pendent of the effects of CRP and SJC on radiographic
progression [22, 39]. The present data also show that
MRI-detected inflammation is associated with severity of
joint damage, independent of other measures of inflam-
mation. Hence in the last two steps of the mediation
analysis, adjustments for CRP and SJC were made. The
finding that the effect size of age decreased after additional
adjustment for MRI-detected inflammation suggests
that the effect of more severe joint damage at higher
age is partly mediated by the presence of more severe
MRI-detected inflammation at an older age. In other
words, it suggests that MRI-inflammation acts in the
so-called causal path [36].
Interestingly, some recent evidence suggested that older
age might also be associated with presence of more
MRI-detected inflammation in symptom-free persons [42].More studies are needed to determine the validity of these
results, and to differentiate disease-related inflammation
on MRI from variations that are present in the general
population. Nonetheless, in our view this does not affect
the validity of the present results. If MRI-detected inflam-
mation also occurs at an older age in people without RA,
this most likely does not affect the mediation analyses in
RA and does not influence the decrease in the beta value
for age between steps 2 and 3.
We explored whether the higher SHS scores at older
age were due to age-related degeneration. We have tried
to detangle these effects by evaluating JSN scores and
erosion scores separately and predilection locations for
degenerative changes separately. Although these compari-
sons do not allow us to make conclusions about the
causality, degenerative changes at an older age appear
insufficient to explain the observed association between
age and severity of joint damage.
Similarly, it can be questioned whether more severe
MRI-detected inflammation is RA-specific or age-specific.
This is even more difficult to discriminate as the RAMRIS
was derived for RA; degenerative features such as JSN and
osteophytes were not included; also the locations assessed
by RAMRIS are specific for RA. The CMC-1 joint is in-
cluded but is known to be affected by degeneration as
well. When we evaluated the BME scores in the base of
metacarpal-1 and trapezium (the two bones together
forming CMC-1), the correlation with age was not signifi-
cant (ρ = 0.24, p = 0.07) whilst the BME score obtained in
other bones in the wrist was positively correlated with age
(ρ = 0.41, p = 0.002). This suggests that the higher
MRI scores seen in patients with RA at higher age
were not primarily due to degeneration (in the process
of osteoarthritis).
Degeneration in the light of osteoarthritis may be dif-
ferent from the more global effects of wear and tear. We
cannot exclude that part of the effect of greater MRI-
detected inflammation at an older age is due to wear
and tear. Part of the observation of more radiographic
erosions at older ages can, in the same path, also be due
to wear and tear. If this is true, hand and foot radiographs
of healthy people at older ages would also show erosions
according to the SHS method. To the best of our know-
ledge, radiographic studies on the hands and feet of
healthy persons of different age categories have not
been done.
It has been suggested that older patients are treated
differently in comparison to younger patients [43–46], but
others have argued against this [47]. The majority of
patients studied here were included in periods when
early, tailored, treatment and use of biologic agents were
uncommon. Importantly, treatment most likely does not
affect the results of our study as differences in radio-
graphic joint damage were already present at baseline.
Mangnus et al. Arthritis Research & Therapy  (2015) 17:222 Page 9 of 10The differences were already present before the start of
treatment, so treatment was not a likely mediator.
Analyses were adjusted for gender to account for differ-
ences in male/female ratios at different ages. Additionally,
women have hormonal changes during their lifetime.
When repeating the mediation analyses in men only, no
differences were observed (data not shown), suggesting
that gender was not a confounder.
The strength of this study is that five cohorts with longi-
tudinal data were studied. The cohorts used different in-
clusion criteria, but despite these differences, all cohorts
had more radiographic joint damage with older age at dis-
ease onset. This replication supported the validity of the
association between age and severity of joint damage. A
limitation is that the mediation analyses were performed
using data from one cohort only. However, data on the
complete set of potential mediators were not available for
the other datasets. Another limitation is the relatively
small number of patients with RA with baseline MRI data
and 1-year follow up in relation to the large cohorts of pa-
tients with radiographic data. This is due to the fact that
in our setting MRI was not available until a few years ago.
Notably, the effect size of age on radiographic joint
damage in this small patient group of patients with RA
was almost similar to that of the larger RA datasets.Conclusions
The present study convincingly showed that patients with
RA diagnosed at an older age already have more joint
damage on disease presentation, and this effect remains
during the disease course. This effect might be partially
explained by more severe local inflammation at an older
age. Future studies are needed to elucidate the biological
mechanisms determining inflammation severity and RA
severity and changes during the patient’s lifetime.Additional files
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